Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sarissa Biomedical

Sarissa Biomedical
2002 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$750K LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of novel biosensors designed to offer measurement of neuroactive chemicals during in vitro and in vivo studies for research and clinical diagnostic applications. The company's biosensors are minimally invasive, coupled with a broad linear range and have accuracy and reproducibility, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Unit 4B, Vanguard Centre
  • Sir William Lyons Road, Warwick University Science Park
  • Coventry CV4 7EZ
  • England, United Kingdom

+44 024 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sarissa Biomedical’s full profile, request a free trial.

Sarissa Biomedical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 08-Mar-2019 $750K 00.00 00.000 Completed Clinical Trials - General
10. Grant 17-May-2018 00.000 00.000 Completed Clinical Trials - General
9. Later Stage VC 12-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
8. Later Stage VC 31-Mar-2017 00000 00.000 00.000 Completed Generating Revenue
7. Grant 04-Jul-2016 00000 00.000 Completed Clinical Trials - General
6. Later Stage VC 22-Dec-2015 00000 00.000 00.000 Completed Generating Revenue
5. Later Stage VC 12-Aug-2014 00000 00.000 00.000 Completed Startup
4. Later Stage VC 02-Dec-2010 00000 00.00 00.000 Completed Generating Revenue
3. Grant 01-Jan-2010 $898K Completed Generating Revenue
2. Early Stage VC 13-Oct-2004 $898K $898K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sarissa Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.0 00.0 00 00.0 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 128,138 $0.013042 $2.88 $2.88 1x $2.88 15.69%
Preference 84,779 $0.013042 $2.88 $2.88 1x $2.88 10.38%
To view this company’s complete Cap Table, request access »

Sarissa Biomedical Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Small Business Research Initiative Government 000 0000 000000 0
University of Warwick Foundation Limited Partner Minority 000 0000 000000 0
Wren Capital Angel Group Minority 000 0000 000000 0
Advantage West Midlands Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Sarissa Biomedical Executive Team (6)

Name Title Board
Seat
Contact
Info
Everard Mascarenhas Ph.D Board Member & Chief Executive Officer
Nicholas Dale Ph.D Co-Founder, Chief Technology Officer & Board Member
E. Llaudet Co-Founder & Research Assistant
Bruno Frenguelli Non-Executive Director
Tim O'Connell Financial Director

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Sarissa Biomedical Board Members (6)

Name Representing Role Since Contact
Info
Everard Mascarenhas Ph.D Sarissa Biomedical Board Member & Chief Executive Officer 000 0000
George Zajicek Self Board Member 000 0000
Nicholas Dale Ph.D Sarissa Biomedical Co-Founder, Chief Technology Officer & Board Member 000 0000
Quentin Compton-Bishop Sarissa Biomedical Director 000 0000
William Moffitt III Self Chairman 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »